Haitham Hamoda
@haithamhamoda.bsky.social
Consultant Gynaecologist, Subspecialist Repro Medicine&Surgery, Lead Menopause Service, King’s College Hospital, Trustee & Past Chair British Menopause Society
Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process - The Lancet www.thelancet.com/journals/lan...
A very welcome change. Moving away from the term ‘polycystic’, an often misinterpreted description, is much needed.
A very welcome change. Moving away from the term ‘polycystic’, an often misinterpreted description, is much needed.
www.thelancet.com
May 14, 2026 at 7:57 AM
Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process - The Lancet www.thelancet.com/journals/lan...
A very welcome change. Moving away from the term ‘polycystic’, an often misinterpreted description, is much needed.
A very welcome change. Moving away from the term ‘polycystic’, an often misinterpreted description, is much needed.
IMS recommendations on women’s midlife health and menopause - A comprehensive resource to guide HCP to optimise their support and guidance to women going through the menopause transition and beyond
We are delighted to announce the publication of the IMS Recommendations and Key Messages on Women’s Midlife Health and Menopause. An easily accessible summary of the recommendations and key messages, and accompanying Editorial are also free to access:
🔗 www.imsociety.org/statements/i...
🔗 www.imsociety.org/statements/i...
March 29, 2026 at 8:07 AM
IMS recommendations on women’s midlife health and menopause - A comprehensive resource to guide HCP to optimise their support and guidance to women going through the menopause transition and beyond
Reposted by Haitham Hamoda
We are delighted to announce the publication of the IMS Recommendations and Key Messages on Women’s Midlife Health and Menopause. An easily accessible summary of the recommendations and key messages, and accompanying Editorial are also free to access:
🔗 www.imsociety.org/statements/i...
🔗 www.imsociety.org/statements/i...
March 25, 2026 at 4:04 PM
We are delighted to announce the publication of the IMS Recommendations and Key Messages on Women’s Midlife Health and Menopause. An easily accessible summary of the recommendations and key messages, and accompanying Editorial are also free to access:
🔗 www.imsociety.org/statements/i...
🔗 www.imsociety.org/statements/i...
IMS recommendations on women’s midlife health and menopause - A comprehensive resource to guide HCP to optimise their support and guidance to women going through the menopause transition and beyond
www.imsociety.org/wp-content/u...
www.tandfonline.com/doi/epdf/10....
www.imsociety.org/wp-content/u...
www.tandfonline.com/doi/epdf/10....
www.imsociety.org
March 25, 2026 at 11:27 PM
IMS recommendations on women’s midlife health and menopause - A comprehensive resource to guide HCP to optimise their support and guidance to women going through the menopause transition and beyond
www.imsociety.org/wp-content/u...
www.tandfonline.com/doi/epdf/10....
www.imsociety.org/wp-content/u...
www.tandfonline.com/doi/epdf/10....
mailchi.mp/867c7b68d3f2...
NICE supports NHS prescribing of fezolinetant - This is very welcome news and a good option to have for women who can’t or don’t wish to take HRT
NICE supports NHS prescribing of fezolinetant - This is very welcome news and a good option to have for women who can’t or don’t wish to take HRT
NICE supports NHS prescribing of fezolinetant
mailchi.mp
March 11, 2026 at 10:25 PM
mailchi.mp/867c7b68d3f2...
NICE supports NHS prescribing of fezolinetant - This is very welcome news and a good option to have for women who can’t or don’t wish to take HRT
NICE supports NHS prescribing of fezolinetant - This is very welcome news and a good option to have for women who can’t or don’t wish to take HRT
The use of HRT containing transdermal estradiol in women with a personal history of venous or arterial thromboembolism: A consecutive series of 115 cases www.tandfonline.com/doi/full/10....
The use of HRT containing transdermal estradiol in women with a personal history of venous or arterial thromboembolism: A consecutive series of 115 cases
To assess the risk of further thrombosis with using HRT containing transdermal estradiol in women with a personal history of venous thromboembolism (VTE) or arterial thromboembolism (ATE).We undert...
www.tandfonline.com
January 5, 2026 at 9:36 AM
The use of HRT containing transdermal estradiol in women with a personal history of venous or arterial thromboembolism: A consecutive series of 115 cases www.tandfonline.com/doi/full/10....
Reposted by Haitham Hamoda
Delighted to contribute the #VTE section of the new International #Menopause Society guidance. www.tandfonline.com/doi/full/10.... @isth.org @thrombosisuk.bsky.social @haithamhamoda.bsky.social @btsamuelsonmd.bsky.social @vsnuk1.bsky.social @fniainle.bsky.social @middeldorps.bsky.social
International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause
Following a rigorous systematic review of the literature, the International Menopause Society (IMS) has produced detailed new recommendations and key messages on women’s midlife health, menopause a...
www.tandfonline.com
December 25, 2025 at 2:16 PM
Delighted to contribute the #VTE section of the new International #Menopause Society guidance. www.tandfonline.com/doi/full/10.... @isth.org @thrombosisuk.bsky.social @haithamhamoda.bsky.social @btsamuelsonmd.bsky.social @vsnuk1.bsky.social @fniainle.bsky.social @middeldorps.bsky.social
Reposted by Haitham Hamoda
📄 Read the EMAS statement
https://emas-online.org/emas-statement-on-the-fda-decision-to-remove-black-box-warnings-from-menopausal-hormone-therapy-mht/emas-news/
https://emas-online.org/emas-statement-on-the-fda-decision-to-remove-black-box-warnings-from-menopausal-hormone-therapy-mht/emas-news/
November 17, 2025 at 4:32 PM
www.cnn.com/2025/11/10/h...
This is very welcome news. Important to put risk in perspective. For many women the benefits way outweigh the risks.
This is very welcome news. Important to put risk in perspective. For many women the benefits way outweigh the risks.
‘Black box’ safety warning to be removed from hormone therapy for menopause | CNN
In a pivotal move, the US Food and Drug Administration on Monday said it is taking steps to remove the lengthy “black box” warning on many hormone treatments for women with menopause symptoms — a shif...
www.cnn.com
November 10, 2025 at 10:58 PM
www.cnn.com/2025/11/10/h...
This is very welcome news. Important to put risk in perspective. For many women the benefits way outweigh the risks.
This is very welcome news. Important to put risk in perspective. For many women the benefits way outweigh the risks.
Reposted by Haitham Hamoda
📅 Webinar today → https://f.mtr.cool/rnvyvhwjdw
#EMASVoices #HRLeadership
#WorldMenopauseAndWorkDay #EMASVoices #HR
#EMASVoices #HRLeadership
#WorldMenopauseAndWorkDay #EMASVoices #HR
Menopause in the Workplace
EMAS Menopause in the Workplace initiative aims to raise awareness of the impact of menopause and to develop policies that promote equality, diversity, and inclusion in the workplace.
f.mtr.cool
September 7, 2025 at 7:01 AM
Reposted by Haitham Hamoda
📅 And join our free webinar today, 14:00–16:00 CEST
Menopause in the Workplace
EMAS Menopause in the Workplace initiative aims to raise awareness of the impact of menopause and to develop policies that promote equality, diversity, and inclusion in the workplace.
f.mtr.cool
September 7, 2025 at 9:14 AM
📅 And join our free webinar today, 14:00–16:00 CEST
Reposted by Haitham Hamoda
Today is World Menopause and Work Day
Prof. Petra Stute: “My one ask to employers: include menopause in workplace health strategies & track outcomes like retention & sick leave. Ignoring menopause costs more than addressing it”
https://f.mtr.cool/maxesrfxov
Prof. Petra Stute: “My one ask to employers: include menopause in workplace health strategies & track outcomes like retention & sick leave. Ignoring menopause costs more than addressing it”
https://f.mtr.cool/maxesrfxov
September 7, 2025 at 9:14 AM
Today is World Menopause and Work Day
Prof. Petra Stute: “My one ask to employers: include menopause in workplace health strategies & track outcomes like retention & sick leave. Ignoring menopause costs more than addressing it”
https://f.mtr.cool/maxesrfxov
Prof. Petra Stute: “My one ask to employers: include menopause in workplace health strategies & track outcomes like retention & sick leave. Ignoring menopause costs more than addressing it”
https://f.mtr.cool/maxesrfxov
x.com
August 30, 2025 at 9:22 AM
Reposted by Haitham Hamoda
Addressing the challenges of misinformation about menopause. My article was just published in the Green Journal, who have made it free for all to read! journals.lww.com/greenjournal...
Addressing the Challenges of Online Misinformation and... : Obstetrics & Gynecology
ices that are unsupported by the literature and guidelines or, in some cases, harmful. Health care professionals committed to evidence-based medicine should be aware of myths and misleading menopause-...
journals.lww.com
August 2, 2025 at 9:11 PM
Addressing the challenges of misinformation about menopause. My article was just published in the Green Journal, who have made it free for all to read! journals.lww.com/greenjournal...
www.kcl.ac.uk/news/menopau... interesting study. Perimenopausal women had significantly more psychosocial symptoms than pre & postmenopausal women.
as ADHD traits increased, so did many menopausal difficulties.
This may indicate women attribute menopausal complaints differently if they have ADHD.
as ADHD traits increased, so did many menopausal difficulties.
This may indicate women attribute menopausal complaints differently if they have ADHD.
Menopausal difficulties increase in line with the severity of ADHD symptoms
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London established a complex relationship between ADHD and the menopause in which menopausal symptoms...
www.kcl.ac.uk
August 1, 2025 at 7:12 AM
www.kcl.ac.uk/news/menopau... interesting study. Perimenopausal women had significantly more psychosocial symptoms than pre & postmenopausal women.
as ADHD traits increased, so did many menopausal difficulties.
This may indicate women attribute menopausal complaints differently if they have ADHD.
as ADHD traits increased, so did many menopausal difficulties.
This may indicate women attribute menopausal complaints differently if they have ADHD.
www.nejm.org/doi/full/10....
An important study with positive findings showing Elinzanetant resulting in significantly lower frequency of vasomotor symptoms associated with adjuvant endocrine therapy in women with hormone receptor positive breast cancer compared to placebo.
An important study with positive findings showing Elinzanetant resulting in significantly lower frequency of vasomotor symptoms associated with adjuvant endocrine therapy in women with hormone receptor positive breast cancer compared to placebo.
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer | NEJM
Women receiving endocrine therapy for hormone receptor (HR)–positive breast cancer
or its prevention among those at high risk for breast cancer commonly have vasomotor
symptoms. Data are lacking on...
www.nejm.org
June 2, 2025 at 9:43 PM
www.nejm.org/doi/full/10....
An important study with positive findings showing Elinzanetant resulting in significantly lower frequency of vasomotor symptoms associated with adjuvant endocrine therapy in women with hormone receptor positive breast cancer compared to placebo.
An important study with positive findings showing Elinzanetant resulting in significantly lower frequency of vasomotor symptoms associated with adjuvant endocrine therapy in women with hormone receptor positive breast cancer compared to placebo.
